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abstract
 
The rat 
 
g
 
-aminobutyric acid transporter GAT1 expressed in 
 
Xenopus 
 
oocytes was labeled at Cys74, and
at one or more other sites, by tetramethylrhodamine-5-maleimide, without signiﬁcantly altering GAT1 function.
Voltage-jump relaxation analysis showed that ﬂuorescence increased slightly and monotonically with hyperpolariza-
 
tion; the ﬂuorescence at 
 
2
 
140 mV was 
 
z
 
0.8% greater than at 
 
1
 
60 mV. The time course of the ﬂuorescence relax-
ations was mostly described by a single exponential with voltage-dependent but history-independent time constants
ranging from 
 
z
 
20 ms at 
 
1
 
60 mV to 
 
z
 
150 ms at 
 
2
 
140 mV. The ﬂuorescence did not saturate at the most negative
potentials tested, and the midpoint of the ﬂuorescence–voltage relation was at least 50 mV more negative than the
 
midpoint of the charge–voltage relation previously identiﬁed with Na
 
1
 
 binding to GAT1. The presence of 
 
g
 
-ami-
nobutyric acid did not noticeably affect the ﬂuorescence waveforms. The ﬂuorescence signal depended on Na
 
1
 
concentration with a Hill coefﬁcient approaching 2. Increasing Cl
 
2
 
 concentration modestly increased and acceler-
ated the ﬂuorescence relaxations for hyperpolarizing jumps. The ﬂuorescence change was blocked by the GAT1 in-
hibitor, NO-711. For the W68L mutant of GAT1, the ﬂuorescence relaxations occurred only during jumps to high
positive potentials, in agreement with previous suggestions that this mutant is trapped in one conformational state
except at these potentials. These observations suggest that the ﬂuorescence signals monitor a novel state of GAT1,
 
intermediate between the 
 
E
 
*
 
out
 
 and 
 
E
 
out
 
 states of Hilgemann, D.W., and C.-C. Lu (1999. 
 
J. Gen. Physiol
 
.
 
 
 
114:459–
476). Therefore, the study provides veriﬁcation that conformational changes occur during GAT1 function.
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INTRODUCTION
 
Speciﬁc Na
 
1
 
-coupled transporters are present on neu-
ronal and glial membranes for all known low–molecu-
lar weight neurotransmitters or, in the case of acetyl-
choline, for their catabolites. These transporters are
thought to be responsible for removal of the neu-
rotransmitter from the vicinity of receptors and are
therefore important for termination of synaptic trans-
mission. To inﬂuence the time course of synaptic trans-
mission, this removal would be expected to occur on a
time scale of milliseconds for ligand-gated channels,
and on a time scale of hundreds of milliseconds for
G-protein–coupled receptors. This postulated role for
neurotransmitter transporters in neurotransmission
calls for direct measurements of the time course of
neurotransmitter transporter action.
Besides their postulated physiological function, neu-
rotransmitter transporters are pharmacologically im-
portant: they appear to be the sites of action for impor-
tant abused (cocaine) and therapeutic (antidepressants,
psychostimulants, antiepileptics) drugs (Kuhar et al.,
1991; Amara and Kuhar, 1993; Lester et al., 1996). De-
spite their pharmacological function, the molecular
mechanisms of these inhibitors are not known. Under-
standing the detailed mechanism of neurotransmitter
transporter action would facilitate rational drug design.
Therefore it is an important goal to study the physical
mechanism of neurotransmitter transporters at the mo-
lecular level. The driving force for transporting neu-
rotransmitter across the cell membrane comes from the
electrochemical gradient of the cotransported ions, pri-
marily Na
 
1
 
. Na
 
1
 
, Cl
 
2
 
, and sometimes K
 
1
 
 are cosubstrates
with a stoichiometry of 1 or 2 mol/mol of neurotransmit-
ter (Rudnick, 1977; Kanner, 1978; Rudnick and Nelson,
1978; Kanner and Bendahan, 1982; Pastuszko et al., 1982;
Radian and Kanner, 1983, 1985). With the molecular
 
cloning of the 
 
g
 
-aminobutyric acid (GABA) transporter
GAT1 (Guastella et al., 1990), and the subsequent clon-
ing of many other neurotransmitter transporters (Blakely
et al., 1991; Hoffman et al., 1991; Pacholczyk et al., 1991;
Shimada et al., 1991; Usdin et al., 1991), research on
neurotransmitter transporters has been accelerating.
Sequence analysis shows that some neurotransmitter
transporters, such as GAT1 and the serotonin transporter
SERT, are homologous members of a family whose mem-
bers are postulated to contain 12 transmembrane helices
 
and 
 
z
 
600 amino acid residues. Structure–function stud-
ies of transporters in this GAT1 family, based on site-
directed mutagenesis and heterologous expression, have
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identiﬁed certain residues that are critical for transporter
function and have provided clues about some functional
domains (Mabjeesh and Kanner, 1992; Bendahan and
Kanner, 1993; Pantanowitz et al., 1993; Kleinberger-
Doron and Kanner, 1994; Penado et al., 1998). Neverthe-
less, the actual molecular structure and physical mecha-
nism(s) of transport is still not known. This situation calls
for additional biophysical study of these transporters.
In this research, we used combined electrophysiologi-
cal and optical techniques to study the molecular mech-
anism of neurotransmitter transporter function. Electro-
physiology can be used for transporter studies because
ion binding and translocation steps, which are partial re-
actions in the transport cycle, produce electrical signals.
For GAT1, electrophysiology is employed to assess rates,
reaction steps, and turnover numbers (Mager et al.,
1993, 1996; Hilgemann and Lu, 1999; Lu and Hilge-
mann, 1999a,b). On the other hand, recording of ﬂuo-
rescent probes has more recently been applied to moni-
tor the conformational changes of channel proteins
(Mannuzzu et al., 1996; Cha and Bezanilla, 1997, 1998;
Siegel and Isacoff, 1997; Baker et al., 1998; Loots and Isa-
coff, 1998) and transporters (Loo et al., 1998) expressed
in cell membranes. Such experiments have provided im-
portant insights into the motion of S2 and S4 segments
of K
 
1
 
 channel domains and the Na
 
1
 
-glucose transporter.
For the experiments, we built an apparatus for simul-
taneous electrophysiological and optical recording
from 
 
Xenopus
 
 oocytes. We detected and analyzed con-
formational transitions at GAT1 with a time resolution
of milliseconds. These results may contribute to ex-
plaining the molecular mechanism of transporter func-
tion and drug action, which are important for under-
standing the physiological and pathological role of
neurotransmitter transporters in native cells.
 
Our studies were enhanced by the use of two previously
characterized GAT1 mutants. (a) The C74A mutant func-
 
tions rather similarly to wild type (WT),
 
1
 
 yet is insensitive
to the sulfhydryl reagent MTS-ethyltrimethylammonium
(MTSET) (Yu et al., 1998). This mutant was therefore ex-
pected to undergo normal conformational changes, but
to lack a crucial site for labeling by sulfhydryl-speciﬁc
probes. Indeed, we ﬁnd that C74A-GAT1 is labeled to a
lesser extent than WT-GAT1 by our ﬂuorescent probe,
tetramethylrhodamine maleimide. (b) The W68L mu-
 
tant appears to be locked in a high-afﬁnity state for Na
 
1
 
(Mager et al., 1996). We expected that this W68L-GAT1
would show WT levels of labeling but reduced ﬂuores-
cence relaxations. This expectation is fulﬁlled.
 
MATERIALS AND METHODS
 
Reagents and Solutions
 
The ﬂuorescent dye tetramethylrhodamine-5-maleimide was pur-
 
chased from Molecular Probes, Inc. The blocking reagent 3-male-
imidopropionic acid was purchased from Aldrich Chemical Co.
MTSET was purchased from Toronto Research Chemicals. The
GAT1 inhibitor NO-711 was purchased from Research Biochemi-
cals, Inc. Other reagents were purchased from Sigma Chemical
Co. The recording solution, ND96, contained 96 mM NaCl, 2
mM KCl, 1 mM MgCl
 
2
 
, and 5 mM HEPES, pH 7.4. The incuba-
tion solution contained ND96 plus 2% horse serum. The NMDG
substitution for Na
 
1
 
 contained 96 mM NMDG instead of Na
 
1
 
 in
the ND96 solution. The gluconate substitution of Cl
 
2
 
 contained
96 mM gluconate instead of Cl
 
2
 
 in the ND96 solution.
 
Oocyte Expression
 
The high-efﬁciency expression system for GABA and serotonin
transporters in 
 
Xenopus
 
 oocytes (Mager et al., 1993) was used for
rGAT1 expression, with modiﬁcations for the ﬂuorescence label-
ing. In brief, 30 ng cRNA of WT-rGAT1 (Mager et al., 1993) or
C74A-rGAT1 (Yu et al., 1998) was injected into stage VI oocytes
and the cells were incubated at 18
 
8
 
C for 1 d, and then moved to
12
 
8
 
C for incubation for 5 d. At the end of the sixth day of incuba-
tion, the oocytes were treated for ﬂuorescence labeling, as de-
scribed in the following.
 
Fluorescence Labeling and MTSET Reaction
 
At the end of the sixth day of incubation, the oocytes were reacted
 
with 10 mM 3-maleimidopropionic acid in ND96 for 1 h at 18
 
8
 
C, to
block the endogenous reactive sulfhydryl groups in the oocyte
membrane. After this blocking reaction, the oocytes were washed
and brought to 18
 
8
 
C incubation for 1 d. On the eighth day after
cRNA injection, the oocytes were incubated in ND96 solution con-
taining 5 mM tetramethylrhodamine-5-maleimide (TMRM) for 1 h
on ice as described (Mannuzzu et al., 1996), or at room tempera-
ture for 30 min; these two treatments produced similar results in
the ﬂuorescence signals. The labeled oocytes were then washed and
incubated in ND96, ready for recording and GABA uptake assay.
For MTSET reactions, oocytes were incubated in ND96 containing
3.75 mM MTSET for 0.5 h at room temperature (Yu et al., 1998).
 
The result of TMRM labeling was examined by measuring the
ﬂuorescence intensity of the oocyte surface at the animal pole with
the apparatus described below, and by ﬂuorescence confocal imag-
ing of the oocyte surface using a MRC-600 confocal microscope
 
(MRC-600; Bio-Rad Laboratories) with a 10
 
3
 
, NA 0.5 objective.
 
Apparatus
 
The recording setup, as shown in Fig. 1, consists of a microscope,
a photomultiplier tube (PMT) attached to the side port of the
microscope, and conventional two-electrode voltage clamp in-
struments. The inverted ﬂuorescence microscope (IX-70-FLA;
Olympus Corp.) is ﬁtted with a stabilized 100-W Hg light source
and an oil-immersion objective of 40
 
3
 
, NA 1.3. The dichroic mir-
ror is the high Q TRITC set from Chroma Technology Corp. The
PMT (R928P; Hamamatsu Phototonics) is in a housing originally
built by Photon Technology, Inc. The oocyte is placed on the mi-
croscope stage and is visualized for electrophysiology by a sepa-
rate stereomicroscope. The exciting beam was attenuated by fac-
tors approaching 300 by neutral density ﬁlters; therefore, an in-
candescent lamp would probably sufﬁce. A digitally controlled
(i.e., ﬁnger-operated) shutter blocked the beam, except during
actual data trials, to minimize bleaching. The emission signal
from the oocytes was appropriately ampliﬁed and ﬁltered at 200
 
1
 
Abbreviations used in this paper:
 
 GABA, 
 
g
 
-aminobutyric acid; MTSET,
methanethiosulfonate-ethyltrimethylammonium; PMT, photomulti-
plier tube; TMRM, tetramethylrhodamine-5-maleimide; WT, wild type. 
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Hz by an eight-pole low-pass ﬁlter (902-LPF; Frequency Devices,
Inc.). Each trace was acquired and averaged over 30 sweeps by an
Axon Digidata interface and pCLAMP 7 (Axon Instruments). A
HumBug (Quest Scientiﬁc) removed the remaining 60 Hz. Two-
electrode voltage clamp procedures were used as described
(Quick and Lester, 1994; Mager et al., 1998). We optimized the
apparatus using the 
 
Shaker
 
 H4 R359C mutation, generously pro-
vided by E. Isacoff (Univerisity of California, Berkely, Berkely,
CA), and found 31% changes in ﬂuorescence upon voltage depo-
larization from 
 
2
 
80 to 
 
1
 
40 mV. This signal is comparable with
previous results with a similar apparatus (Mannuzzu et al., 1996).
 
Off-line Data Analysis
 
Steady state ﬂuorescence values were measured as the average
over the ﬁnal 200 ms at the test potential. For kinetic analyses such
as those shown in Figs. 6–9 (below), signals were subjected to fur-
ther averaging across cells, digital ﬁltering (50 Hz eight-pole
Bessel), baseline alignment, and linear detrending where appro-
priate. Waveforms were ﬁt to single or double exponentials with
routines in ORIGIN 5 and CLAMPFIT 8. In preliminary analyses,
we veriﬁed that (a) the baseline alignment did not result in sys-
tematic voltage-dependent shifts, and (b) the linear detrending
did not result in systematic elimination of slow exponential com-
ponents with time constants of 
 
z
 
500 ms or less. We cannot rule
out the possibility that relaxations with larger time constants
would be detected by test potentials longer than those used here.
Because the ﬂuorescence relaxations were small and noisy, ac-
curate analysis of these relaxations is a major topic of this paper.
Therefore, several details of the analysis are evaluated in the 
 
re-
sults
 
. Figs. 5 and 6 show the progression from raw to analyzed
traces for two important data sets. Figs. 7 and 8 present tests for
history dependence. Figs. 9 and 10 compare two methods for an-
alyzing the voltage dependence of the ﬂuorescence relaxations.
 
GABA Uptake Assay
 
[
 
3
 
H]GABA uptake experiments were performed as follows. Oo-
cytes expressing GAT1 were incubated in ND96 solution contain-
ing various concentrations of GABA and trace amounts of
[
 
3
 
H]GABA for 20 min, and then washed with ND96 solution ﬁve
times. Each individual oocyte was then dissolved in 1 ml 10% SDS
and the radioactivity was measured using a scintillation counter
(LS 5000 TD/TA; Beckman Instruments Inc.).
 
RESULTS
 
TMRM Treatment of GAT1 Does Not Affect GABA Uptake
 
Fig. 2 presents results of [
 
3
 
H]GABA uptake experiments
on oocytes expressing WT-GAT1 and exposed either to
TMRM or MTSET. TMRM labeling did not signiﬁcantly
affect GABA uptake: for eight cells measured at 128 mM
extracellular GABA, the uptake was 0.32 
 
6
 
 0.02 and
0.33 
 
6
 
 0.02 pmol/oocyte per 20 min in unlabeled and
TMRM-labeled oocytes, respectively. When the data in
Fig. 2 were ﬁt by hyperbolic (or Michaelis-Menten)
dose–response relations, the unlabeled and TMRM-
labeled oocytes yielded virtually identical values: 
 
K
 
m
 
 
 
5
 
83 
 
m
 
M and V
 
max
 
 
 
5 
 
0.54 pmol/oocyte per 20 min. These
 
K
 
m
 
 values are several times higher than the values previ-
ously observed for GAT1 expressed in oocytes (Guastella
et al., 1990). One possible explanation for this observa-
tion is that the prolonged incubation (7 d) followed by
reaction with maleimidopropionic acid (the preblock-
ing step) increases the intracellular Na
 
1
 
 and/or Cl
 
2
Figure  1. Instrumentation for
measuring ﬂuorescence from volt-
age-clamped oocytes. The record-
ing apparatus consists of a micro-
scope (depicted by the objective
and dichroic mirror), a photomul-
tiplier tube attached to the side
port of the microscope, and con-
ventional two-electrode voltage-
clamp instruments. The apparatus
uses a stabilized 100-W Hg light
source coupled to an inverted mi-
croscope (IX-70; Olympus Corp.),
dichroic ﬁlter cubes for delivering
the light, a 403 objective lens, and
a photomultiplier tube to collect
the ﬂuorescence emission. The oo-
cyte is placed on the microscope
stage with its animal pole facing
down and is visualized for electro-
physiology by a separate stereomi-
croscope (not shown). The excit-
ing beam is attenuated by factors
approaching 300. The emission sig-
nal from the oocytes is collected by
the objective lens and sent to the
PMT. Appropriate ampliﬁers and
electronic ﬁlters condition the sig-
nal. The command and output sig-
nals are interfaced with a computer
through A/D and D/A converters. 
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concentration and thereby increases the 
 
K
 
m
 
 for GABA
(Lu and Hilgemann, 1999b). This preblocking step was
done for both unlabeled and TMRM-labeled oocytes.
 
GAT1 and C74A-GAT1 Are Labeled by TMRM
 
Fluorescent labeling of GAT1 by TMRM was veriﬁed by
confocal microscopy (Fig. 3) and was quantiﬁed by PMT
measurements of the ﬂuorescence of the oocyte surface
at the animal pole, where the autoﬂuorescence was par-
tially absorbed by the pigment granules. We also studied
C74A-GAT1, a mutant that is less susceptible to sulfhy-
dryl reagents (Yu et al., 1998). The results are shown in
Table I. It is clear that oocytes expressing either C74A or
WT-GAT1 were labeled more than uninjected oocytes;
furthermore, WT-GAT1 displayed higher ﬂuorescence
than C74A (10.6 versus 6.4 V PMT signal, respectively).
As shown below, the C74A mutant displays the same
maximal function as WT-GAT1 when expressed in oo-
cytes; therefore, the reduced labeling of C74A is proba-
bly not caused by reduced expression levels. It is most
likely that elimination of the cysteine at position 74 de-
creases the labeling by the cysteine-speciﬁc reagent
TMRM. We conclude that Cys74 is labeled by TMRM in
WT-GAT1, in addition to at least one other site that is la-
beled in both WT-GAT1 and the C74A mutant.
 
TMRM Labeled WT-GAT1 and C74A-GAT1 Have Very 
Similar Electrophysiological Properties
 
Fig. 2 showed that reaction with TMRM had little effect
on GABA uptake by GAT1. We also found only small re-
ductions in GABA-induced currents in electrophysio-
 
logical studies. In measurements of transport-associ-
ated currents (200 
 
m
 
M GABA, 
 
2
 
60 mV, measured at
the end of a 40-s application), exposure to TMRM de-
creased currents by 17 
 
6
 
 18% for WT-GAT1 and by 17 
 
6
 
5% for C74A-GAT1 (mean 
 
6
 
 SEM,
 
 n 
 
5 
 
7 and 2, re-
spectively). Fig. 4 presents additional data on electro-
physiological properties of TMRM-labeled WT-GAT1
and C74A-GAT1. Fig. 4 A shows that the time course
and amplitude of GABA-induced current are quite sim-
ilar. Average WT-GAT1 and C74A GABA-induced cur-
rents (100 
 
m
 
M, 
 
2
 
60 mV, 40-s application) in the exper-
iments of Fig. 4 A were 120 
 
6
 
 27 and 140 
 
6
 
 42 nA, re-
spectively (mean 
 
6
 
 SEM,
 
 n 
 
5 
 
8).
We also compared charge movements during voltage-
jump relaxations in the absence of GABA for unin-
jected oocytes, WT-GAT1-injected oocytes, and C74A-
injected oocytes. After each jump, the oocytes express-
ing WT-GAT1 and C74A display transient currents,
which relax to new steady state currents over a time
course of hundreds of milliseconds. The transient cur-
rents have previously been analyzed in detail (Mager et
al., 1993, 1996; Hilgemann and Lu, 1999; Lu and Hilge-
mann, 1999a,b). Examples of the traces will be shown
in Fig. 5 (below). The time integral of the transient cur-
rent is interpreted as the reversible binding of Na
 
1
 
 to
GAT1 in the absence of GABA (Mager et al., 1993,
1996). This integral is plotted against membrane po-
tential in Fig. 4 B, and the data are ﬁt to the Boltzmann
Figure 2. [3H]GABA uptake assayed in oocytes expressing WT-
GAT17. The GABA uptake activity was measured in uninjected
(s), GAT-1 mRNA-injected (n), GAT-1 mRNA-injected and
TMRM-labeled (m), and GAT-1 mRNA-injected and MTSET-
treated (d) oocytes. Each data point is the mean value of measure-
ments from three to four cells, and the error bars indicate SEM.
The curves are the nonlinear ﬁts to hyperbolic dose–response rela-
tions (Michaelis-Menten equation).
Figure 3. Confocal microscopy of Xenopus oocytes labeled with
tetramethylrhodamine as described in materials and methods.
(Left) Injected with WT-GAT1, (right) uninjected. The oocytes are
0.9 mm in diameter. The more intense ﬂuorescence is at the ani-
mal pole.
 
TABLE I
 
Fluorescence Intensity of Oocyte Membrane
 
Sample Uninjected C74A-injected WT-injected
Fluorescence intensity, V 2.1 
 
6
 
 0.1 6.4 
 
6
 
 0.6 10.5 
 
6
 
 0.5
Fluorescence intensity was measured as the output from the photomulti-
plier tube at a working voltage of 700 V, after 100
 
3
 
 ampliﬁcation. All data
are mean 
 
6
 
 SEM (
 
n
 
 5 7).495 Li et al.
equation (solid line). For both WT-GAT1 and C74A,
V1/2 5 226 mV, Qmax 5 82 nC, and kT/qzd 5 25 mV.
V1/2 is the voltage at which charge movements are half
completed, Qmax corresponds to the complete move-
ment of charges between the membrane and the me-
dium, z is the charge of the particle moving, d is the
fraction of the membrane ﬁeld through which the
charge moves, q is the elementary charge, and k and T
have their usual meanings. The values for V1/2, Qmax,
and kT/qzd are similar to previously reported values for
WT-GAT1 (227 mV, 80 nC, and 28 mV, respectively;
Mager et al., 1993, 1996).
Interactions between TMRM and MTSET in
Fluorescent Labeling
Yu et al. (1998) reported that exposure to another sulf-
hydryl-reactive reagent, MTSET, caused nearly com-
plete inhibition of WT-GAT1 transport-associated cur-
rents and charge movements. Since the C74A mutant
was not sensitive to MTSET, the inhibitory effects of
MTSET appear to be due exclusively to reaction with
Cys74. Our ﬂuorescence experiments did not employ
MTSET-treated oocytes, but we compared the actions
of MTSET and TMRM to determine whether TMRM la-
bels GAT1 by reacting at the same cysteine residue(s)
as MTSET. MTSET treatment blocked the uptake of
[3H]GABA by WT-GAT1 almost completely: from eight
cells measured at 128 mM extracellular GABA, the up-
take was 0.05 6 0.01 pmol/oocyte per 20 min with MT-
SET treatment (Fig. 2). In contrast, TMRM labeling
had no detectable effect on GABA uptake by WT-GAT1.
The C74A transporter was much less sensitive to MT-
SET inhibition than WT-GAT1 (z40% decrease, data
not shown), in agreement with the electrophysiological
data of Yu et al. (1998).
For the experiments presented in Table II, ﬂuores-
cence was measured on oocytes reacted with TMRM
and/or MTSET in all possible sequences. As expected
from the data of Table I, the ﬂuorescence intensity of
TMRM was less in C74A-GAT1 than in WT-GAT1-
expressing oocytes. Furthermore, the ﬂuorescence inten-
sity of TMRM-reacted WT-GAT1 oocytes was reduced by
almost 50% when TMRM treatment was followed by
MTSET reaction. For C74A-GAT1 oocytes, the percent
reduction in the TMRM ﬂuorescence intensity by MT-
SET was greater, 76%; however, the absolute value of
the decrease in ﬂuorescence signal was roughly equal
(3–4 V) in the two cases. Furthermore, the ﬂuores-
cence intensity for TMRM-labeled WT-GAT1 also ex-
ceeded that for TMRM-labeled C74A-GAT1 by 3–4 V.
These results indicate (a) that the ﬂuorescence signal
in WT-GAT1 is caused by TMRM reaction with Cys74
and also with another residue, and (b) that TMRM ﬂu-
orescence at this second residue is reduced by subse-
quent reaction with MTSET, via an unknown mecha-
nism. Because the C74A transporter activity is not
blocked by MTSET, it is clear that reaction of MTSET
with cysteines other than Cys74 does not inhibit trans-
porter function. Table II also presents results of the re-
verse series of exposures. After MTSET pretreatment,
exposure to TMRM results in an increment of z4 V in
ﬂuorescence signals at both WT-GAT1 and C7A-GAT1.
In the most straightforward interpretation of this re-
sult, MTSET alkylation prevents TMRM from labeling
Cys74, but allows labeling at non-Cys74 sites.
We attempted to extend these observations in a set of
electrophysiological measurements on oocytes before
and after sequential TMRM and MTSET exposure.
However, these dual exposures and repeated impale-
ments rendered the oocytes so unhealthy that the re-
sults were inconclusive. Our experiments yield no deci-
sive information about the fraction of Cys74 residues
that are labeled by TMRM; we assume, but cannot
prove, that this fraction is near unity. Nevertheless, the
data do suggest that roughly half the steady state ﬂuo-
rescence signal arises from TMRM bound to Cys74.
Furthermore, C74A-GAT1 provides a useful contrast
to WT-GAT1 because C74A-GAT1 functions like WT-
Figure 4. Comparison of WT-
GAT1 and C74A electrophysiol-
ogy after labeling with TMRM.
Oocytes expressing WT-GAT1
and C74A-GAT1 were exposed to
TMRM as described in materi-
als and methods. (A) GABA-
induced current was measured at
a holding potential of 260 mV
during perfusion of 100 mM
GABA for a period of 4 s. The
traces are typical of eight cells.
(B) The charge movement (DQ)
was calculated by integrating the
transient current induced by a
voltage jump from a holding potential of 240 mV to various test potentials, as shown in Fig. 5, middle. Each data point shows the average
value from 40 cells for WT-GAT1 (h) and 15 cells for C74A-GAT1 (j). The error bars indicate SEM. The curve is a Boltzmann distribution
with the indicated parameters.496 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
GAT1, but is not labeled by TMRM at position Cys74.
However, both MTSET and TMRM appear to react with
one or more additional sites on GAT1. These observa-
tions provide the background for time-resolved mea-
surements on TMRM-labeled GAT1 ﬂuorescence dur-
ing voltage jumps, reported in detail below.
Voltage Jumps Induce Fluorescence Changes in
TMRM-labeled rGAT1
Fig. 5 presents a survey of simultaneous electrophysio-
logical and optical signals recorded from oocytes in the
apparatus described in Fig. 1. We used the voltage-jump
protocol introduced by Mager et al. (1993) to elicit
transient charge movements at GAT1 in the absence of
GABA. As shown in Fig. 5 (top), the membrane poten-
tial was held at 240 mV, and then jumped to test poten-
tials between 160 and 2140 mV for a period of 350 ms.
In uninjected oocytes reacted with TMRM (Fig. 5 A),
there was no detectable change in ﬂuorescence: the to-
tal variation was ,0.1% over the voltage range studied.
On the other hand, TMRM-labeled oocytes expressing
WT-GAT1 (Fig. 5 B) displayed decreased ﬂuorescence
intensity during depolarizing jumps and increased ﬂuo-
rescence intensity during hyperpolarizing jumps. The
total variation over the voltage range from 160 to
2140 mV was z0.8%. Evidently, these ﬂuorescence sig-
nals are due to effects of the voltage jumps on the
GAT1 molecules.
In the C74A mutant, there was a detectable but smaller
ﬂuorescence change, ,0.4% over the range from 160 to
2160 mV (Fig. 5 C). Again, depolarization decreased
and hyperpolarization increased the ﬂuorescence.
Fig. 6 shows the voltage and time dependence of the
ﬂuorescence signals in more detail. In Fig. 6, A and B,
the ﬂuorescence relaxations are ﬁt to single exponen-
tials after suitable averaging and ﬁltering (see materi-
als and methods). For C74A-GAT1, the amplitude of
the ﬂuorescence change was approximately linear with
voltage (Fig. 6 C). For example, the change over the
100-mV ranges from 160 to 240 mV and from 240 to
2140 mV was 0.22 6 0.01% and 0.20 6 0.01%, respec-
tively (mean 6 SEM, n 5 5 oocytes). In contrast, the ﬂu-
orescence signals from WT-GAT1 were nonlinear with
membrane potential: jumps to potentials more negative
than  260 mV resulted in larger increases in ﬂuores-
cence intensity than jumps to potentials more positive
than 260 mV. When expressed as a percentage of
background ﬂuorescence, WT-GAT1 ﬂuorescence relax-
ations at voltages more negative than 260 mV were 1.5-
to 3-fold greater than C74A ﬂuorescence relaxations; but
because the absolute ﬂuorescence intensity was 1.66-
fold higher for oocytes expressing WT-GAT1 than for
the C74A transporter, the absolute values of relaxations
in WT-GAT1 oocytes were 2.5- and 4.5-fold larger than in
C74A-GAT1 oocytes for jumps to 260 and 2140 mV.
The time constant of the ﬂuorescence relaxations
showed much greater voltage dependence for WT-GAT1
than for the C74A mutant (Fig. 6 D). The average time
constant of ﬁve C74A cells was between 75 and 103 ms
for all voltages from 160 to 2140 mV (Fig. 6 D), whereas
the average time constant of ﬁve WT-GAT1 cells in-
creased monotonically from 22 6 1 ms at 160 mV to 151
6 6 ms at 2140 mV, a 6.5-fold change. An exponential ﬁt
of the voltage dependence of the WT-GAT1 time con-
stants gave an e-fold change per 120 mV, but the value
for C74A-GAT1 was at least 600 mV. Thus, although dif-
ferences in ﬂuorescence amplitude between WT-GAT1
and C74A-GAT1 are apparent only at membrane volt-
ages from 260 to 2140 mV (Fig. 6 C), the relaxation ki-
netics differ between WT-GAT1 and the C74A mutant
over almost the entire voltage range accessible to experi-
ment. In other words, the WT-GAT1 relaxation wave-
forms are not a simple sum of a Cys74-independent com-
ponent plus an additional Cys74-speciﬁc component.
Tests for History Independence
In relaxation analysis, it is a fundamental concept that
transition probabilities depend on the present value of
parameters such as membrane potential, drug concentra-
tion, and temperature, but not on the history of these pa-
rameters. The apparently simple behavior of the relax-
ations allowed a test of this concept for the ﬂuorescence
signals (Figs. 7 and 8). The time constant of the ﬂuores-
cence relaxation for WT-GAT1 did not depend strongly
on the prepulse potential for steps to a constant test po-
tential (2140 mV in the experiment of Fig. 7). The sin-
gle-exponential time constant remained in the range
from 122 to 155 ms as the prepulse voltage ranged from
2100 to 160 mV (Fig. 7 C). The amplitude of the expo-
nential component did of course depend on the prepulse
TABLE II
Interactions between MTSET and TMRM in Fluorescence Labeling 
of GAT1
Fluorescence (V)
WT C74A
Control 0.2 6 0.0 (n 5 7)  0.2 6 0.0 (n 5 3)
TMRM* 8.2 6 0.6 (n 5 7) 5.0 6 1.2 (n 5 2)
TMRM followed 
by MTSET‡ 4.9 6 0.8 (n 5 5) 1.2 6 0.5 (n 5 3)
MTSET§ 0.2 6 0.0 (n 5 6) 0.2 6 0.0 (n 5 6)
MTSET followed 
by TMRMi 4.3 6 1.0 (n 5 6) 4.8 6 0.6 (n 5 2)
*5 mM TMRM in ND96 solution was added to the oocyte chamber for 30 min
at room temperature.  ‡After the TMRM treatment and washes, 3.75 mM
MTSET was added to the oocyte chamber for 30 min.  §3.75 mM MTSET in
ND96 solution was added to the oocyte chamber for 30 min. iAfter the
MTSET treatment and washing, 5 mM TMRM in ND96 solution was added to
the oocyte chamber for 30 min.  Fluorescence intensity was measured as
output from the PMT at a working voltage of 600 V, after 1003 amplification.497 Li et al.
potential, and decreased from 0.38% at a prepulse po-
tential of 160 mV to 0.12% at a prepulse potential of
2100 mV (Fig. 7 B). There was an additional compo-
nent, with a time constant ,10 ms, for the largest
jumps (from voltages more positive than zero). This
was a consistent ﬁnding among each of 40 cells tested.
This rapid component has not been examined system-
atically in our experiments.
In the complementary experiment, we studied the ki-
netics of the ﬂuorescence decrease due to a voltage
jump from a constant hyperpolarizing voltage (2140
mV) to varying depolarized levels (between 260 and
Figure 5. A survey of signals obtained with simultaneous recording of voltage-clamp current and ﬂuorescence of TMRM-labeled GAT1
expressed in Xenopus oocytes. The voltage protocol is shown in A, top. The test potentials ranged from 160 to 2140 mV in 20- mV incre-
ments. (Middle) The currents are shown. Arrows point to the transient currents that comprise the GAT1-speciﬁc charge movements.
These transient currents far out last the endogenous capacitive currents of the oocyte membrane. The ﬂuorescence signal is shown as the
change of ﬂuorescence intensity divided by the baseline ﬂuorescence at the holding potential. Signals from an uninjected oocyte are
shown in A. The current and ﬂuorescence traces are the averaged signal from ﬁve cells for WT-GAT1 (B) and C74A-GAT1 (C).
Figure 6. Analysis of the ﬂuo-
rescence relaxations. The ﬂuo-
rescence from Fig. 5 is replotted
for odd-numbered traces (test
potentials between 160 and
2140 mV in 40-mV increments).
The ﬂuorescence relaxations for
WT-GAT1 (A) and C74A–GAT1
(B) were ﬁt to single-exponential
processes, which are superim-
posed on the traces. The ampli-
tude (DF/F) and time constant t
from the ﬁts are plotted as func-
tions of test potential in C and D
for WT-GAT1 (h) and C74A-
GAT1 (d). Error bars indicate
standard error of the ﬁts using
CLAMPFIT 8.498 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
160 mV). The results are shown in Fig. 8. Unlike the
previous experiment, the time constant of the ﬂuores-
cence decrease was dramatically affected by the mem-
brane potential of the test pulse: the time constant in-
creased from 30 6 1 ms at 160 mV to 100 6 3 ms at
260 mV, a threefold increase (Fig. 8 C). At each volt-
age, these time constants are similar to the values mea-
sured for jumps from a prepulse potential of 240 mV
(Fig. 6). Fluorescence relaxations, therefore, appear to
conform to the concept that the relaxation rates de-
pend on the present value of the membrane potential
rather than on its history.
Comparison of Fluorescence and Charge Movement
As noted above, voltage jumps evoke transient capaci-
tive currents at WT-GAT1. The voltage dependence and
kinetics of these charge movements have been analyzed
in detail previously (Mager et al., 1993, 1996; Lu et al.,
1996; Hilgemann and Lu, 1999; Lu and Hilgemann,
1999b), and in this study we found that the TMRM la-
beling procedure does not affect these transient cur-
rents (Fig. 4 B). The transient currents are absent in
uninjected oocytes (Fig. 5). This charge movement rep-
resents Na1 binding with the transporter and/or the
conformational change induced by Na1 binding
(Mager et al., 1993). The time constant of the charge
movement is tens to hundreds of milliseconds, similar
to that of the ﬂuorescence change.
Fig. 9 compares the voltage dependence and kinetics
of the capacitive charge movements with those of the
ﬂuorescence relaxations. Data from ﬁve cells were aver-
aged, and the amplitudes of the ﬂuorescence change
and charge movement were plotted as a function of
membrane voltage. As seen in the ﬁgure, the plot of
ﬂuorescence lies to left of the plot of charge movement
by at least 50 mV (Fig. 9 A). Furthermore, the ﬂuores-
cence shows no sign of saturation with hyperpolariza-
tion, so that the midpoint of the ﬂuorescence–voltage
relation cannot be determined. Although we know that
the midpoint of the charge–voltage relation is approxi-
mately 226 mV (Fig. 4), we know only that the mid-
point of the ﬂuorescence–voltage relation is more neg-
ative than approximately 275 mV. The actual differ-
ence between charge and ﬂuorescence is thus at least
50 mV on the voltage axis.
Despite the similar range of time constants for the
charge movements and the ﬂuorescence signals, they
differ signiﬁcantly in value at almost every voltage tested
between 160 and 2140 mV (Fig. 9 B). Furthermore, the
time constants characterizing the ﬂuorescence change
and charge movement have distinct dependences on
membrane potential (Fig. 9 B). While the time constant
of the ﬂuorescence change increases monotonically with
hyperpolarizing voltages (with perhaps a hint of satura-
tion at the highest negative potentials), the time con-
stant of charge movement shows a maximum at 240 mV
(Fig. 9 B; see also Mager et al., 1996).
An Alternative Subtraction Procedure Conﬁrms the Distinct 
Voltage Dependences of Charge Movement and Fluorescence
Because the ﬂuorescence signals are small, we sought
additional tests of the conclusion that the ﬂuorescence
signal occurs at membrane potentials more hyperpolar-
ized than the charge movement. The amplitude of the
Figure 7. Tests for history de-
pendence: effect of prepulse po-
tential on the ﬂuorescence relax-
ation. (A) Typical ﬂuorescence
traces from one WT-GAT1 cell.
(Top) The voltage protocol is
shown. The results from single-
exponential ﬁts to the rising
phase of the ﬂuorescence are su-
perimposed on the traces. The
amplitude (B) and time constant
(C) from the ﬁt are plotted as
function of prepulse potential.
Error bars indicate standard er-
ror of the ﬁt using CLAMPFIT 8.499 Li et al.
ﬂuorescence relaxations for C74A, expressed as DF/F,
equals that of WT-GAT1 for most of the voltage range
(Fig. 6). As discussed above, WT-GAT1 ﬂuorescence
waveforms cannot be expressed simply as a sum of
Cys74-dependent and -independent terms. Neverthe-
less, we subtracted the ﬂuorescence signal of C74A
from that of WT-GAT1 (both expressed as DF/F) to ap-
proximate a site-speciﬁc ﬂuorescence signal from resi-
due Cys74. The resulting waveforms are shown in Fig.
10 A. Using this analysis, ﬂuorescence relaxations due
to TMRM labeling at C74 appear to occur only at hy-
perpolarized voltages (more negative than 240 mV).
The ﬂuorescence increased with hyperpolarizing mem-
brane potentials; there were no signs of saturation at
Figure 8. Tests for history dependence: effect of test potential on the ﬂuorescence relaxation. (A) Typical traces from the average of 100
sweeps. (Top) The voltage protocol is shown. The results from single-exponential ﬁts to the falling phase of the ﬂuorescence are superim-
posed on the traces. The amplitude (B) and time constant (C) are plotted as functions of the test potential. Error bars indicate standard
error of the ﬁt using CLAMPFIT 8.
Figure 9. Comparison of the
voltage dependence of the ﬂuo-
rescence relaxations and the
charge movements. The normal-
ized amplitude (A) and time
constant (B) from single-expo-
nential ﬁts of the ﬂuorescence
change (s) and charge move-
ment (j). The charge move-
ment data are those plotted in
Fig. 4 B, inverted to simplify the
comparison to ﬂuorescence. Er-
ror bars indicate standard error
of the ﬁt using CLAMPFIT 8.500 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
the most negative membrane potential tested, 2140
mV (Fig. 10 B). The ﬂuorescence relaxation ﬁt well to a
single exponential process with time constant ranging
from 75 to 150 ms at potentials from 240 to 2140 mV
(Fig. 10 C). These observations on voltage dependence
and kinetics agree well with the characteristics of the
unsubtracted traces (Figs. 6–9). Thus, the details of the
signal analyses do not strongly affect the conclusion
that distinct voltage dependences characterize the ﬂuo-
rescence change and the charge movements.
Effect of Substrates
The effect of GAT1 substrates, GABA, Na1 and Cl2 on
the electrophysiological properties of GAT1 was studied
previously in our laboratory (Mager et al., 1993, 1996).
The results show that GABA induces transport-associ-
ated currents that depend on [Na1], [Cl2], [GABA],
and membrane potential. The transport-associated cur-
rent discharges the capacitance of GAT1. In the ab-
sence of GABA, [Na1] and [Cl2] inﬂuence these capac-
itive charge movements as follows. Reduced [Na1] and
[Cl2] shift the charge movement–membrane potential
curve to more hyperpolarized potentials (Mager et al.,
1993, 1996). The shift is more dramatic for Na1 re-
moval than for Cl2 removal. In particular, for a hyper-
polarizing voltage jump from 240 to 2140 mV, the
charge movement is not altered by various concentra-
tions of Cl2, but is blocked by zero concentration of
Na1 (Mager et al., 1993, 1996). All these characteristics
of transport-associated currents and charge movements
were noted, though not studied quantitatively, in the
electrophysiological recordings that accompanied each
ﬂuorescence experiment in the present study.
The effects of changing these substrates on the ﬂuo-
rescence signal of GAT1 are shown in Fig. 11. The top
panels show exemplar ﬂuorescence traces for the volt-
age-jump relaxations from 240 to 2140 mV; The bot-
tom panels present the effects of GAT1 substrates on
the ﬂuorescence amplitude averaged across several
complete voltage-jump experiments, like those of Fig.
5, at test potentials in the range 140 to 2140 mV.
GABA produced virtually no change in the amplitude
of the ﬂuorescence relaxations (although the simulta-
neous voltage-clamp measurements revealed that the
charge movements were shunted and became GABA-
induced currents as expected).
Cl2 substitution with gluconate modestly decreased
the amplitude of ﬂuorescence relaxations, by 10–50%,
at voltages more negative than 260 mV (Fig. 11, B1
and B2). If the effect of Cl2 replacement by gluconate
is treated as a shift in the ﬂuorescence–voltage relation,
the shift amounts to z15 mV in the negative direction.
This is considerably less than the z44-mV negative shift
reported for the same ionic replacement in charge
movement experiments (Mager et al., 1993). Kinetic
analyses on the effects of substrate substitution on the
ﬂuorescence signal (summarized in Table III) reveal
that Cl2 substitution with gluconate introduced a new
slower process with time constant of 308 6 20 ms (n 5
4) to the ﬂuorescence increase. This time constant
should be considered an estimate, because the relax-
ation did not reach steady state during the 500-ms test
Figure 10. An alternative anal-
ysis of voltage dependence. (A)
The ﬂuorescence signal from an
oocyte expressing TMRM-C74A-
GAT1 was subtracted from the
signal from another cell express-
ing TMRM-WT-GAT1. The
curves are single-exponential ﬁts
to the ﬂuorescence relaxations.
(Top) The membrane potential
was held at 240 mV and stepped
to various test potentials. (B)
The amplitudes of the ﬂuores-
cence change were plotted as a
function of membrane poten-
tial. (C) The time constants for
the rising (280,  2100,  2120,
2140) or falling (240 mV)
phase of the ﬂuorescence are
plotted versus the membrane po-
tential. Error bars indicate stan-
dard error of the ﬁt.501 Li et al.
pulse. Nevertheless, the overall effect of Cl2 substitu-
tion was clearly to slow the time course of the ﬂuores-
cence increase with only a modest change in amplitude
(the amplitude of the ﬂuorescence change was 0.41 6
0.01% in the presence of Na1 and Cl2 and 0.37 6
0.01% in the absence of Cl2).
On the other hand, Na1 substitution with NMDG
blocked most of the ﬂuorescence signal. Of .20 cells
studied, for the jump from 240 to 2140 mV, the ampli-
tude of the ﬂuorescence change was decreased by nine-
fold in the absence of Na1, and there were similar re-
ductions at all voltages more negative than 260 mV. The
remaining relaxation had a time constant of 32 6 4 ms
(n 5 4). Table III also shows that the time course of the
ﬂuorescence decrease for the voltage jump from 2140
to 240 mV was not signiﬁcantly affected by Cl2 but was
affected by Na1. In the presence of both Na1 and Cl2,
the ﬂuorescence decrease is a single exponential pro-
cess with time constant of 59 6 1 ms (n 5 4). In the ab-
sence of Cl2 (substitution by gluconate) and presence of
Na1, the time constant of the ﬂuorescence decrease was
56 6 4 ms (n 5 4). The time course of the ﬂuorescence
decrease was dramatically affected by the absence of
Na1: the time constant decreased to 9 6 1 ms (n 5 4).
Na1 Concentration Dependence of the Fluorescence Relaxations
The Na1 dependence of the ﬂuorescence was further
studied by varying the Na1 concentration in the extra-
cellular medium. The results are shown in Fig. 12. To
study the Na1-dependent ﬂuorescence signal, the resid-
ual small ﬂuorescence that is Na1 independent was
subtracted from each trace. Upon voltage jump from
240 to 2140 mV, the ﬂuorescence increased in a sin-
gle-exponential process (Fig. 12 A). Both the ampli-
tude and the time constant of the ﬂuorescence change
depended on the Na1 concentration. Because there
was no apparent saturation with Na1 concentration,
the plot of ﬂuorescence amplitude–Na1 concentration
was ﬁt to a power law (as though it were the foot of a
Hill function). The exponent was 1.8 (Fig. 12 B), which
is consistent with the observation from previous studies
that two Na1 interact with GAT1 (Mager et al., 1993).
The plot of the rate constant of the ﬂuorescence in-
crease upon hyperpolarizing voltage jump, 1/t2140 mV,
vs. [Na1] was ﬁt to a straight line, resulting in a slope of
64 M21 s21 (Fig. 12 C). Although complete removal of
Na1 did dramatically accelerate the ﬂuorescence de-
crease for the jump from 2140 to 240 mV (Table III),
there was no systematic effect of Na1 concentration in
the range from 48 to 96 mM; the rate constant, 1/t240 mV,
varied between 13 and 18 s21 (Fig. 12 D).
Figure 11. Effect of GAT1 sub-
strates GABA, Cl2 and Na1 on
the ﬂuorescence change. (Top)
Typical ﬂuorescence traces from
one cell recorded in solutions
containing various combinations
of GABA, Cl2, and Na1. The
membrane potential was held at
240 mV, stepped to a test poten-
tial of 2140 mV for 550 ms, and
then stepped back to 240 mV.
(Bottom) Voltage dependence of
the amplitude of the ﬂuores-
cence change for the averaged
data from ﬁve oocytes, 6SEM.
The recording solution for the
control traces was ND96, as de-
scribed in materials and meth-
ods. (A) Effect of GABA. The
ﬂuorescence was recorded in the
absence (light traces) and presence (heavy traces) of 100 mM GABA. (B) Effect of Cl2. The ﬂuorescence was recorded in the presence
(light traces) and absence (heavy traces) of 96 mM Cl2. Cl2 was substituted with gluconate. (C) Effect of Na1. The ﬂuorescence was re-
corded in the presence (light traces) and absence (heavy traces) of 96 mM Na1. Na1 was substituted with NMDG.
TABLE III
Parameters for the Rising and Falling Phases of 
TMRM-WT-GAT1 Fluorescence*
In ND96 In Gluconate In NMDG
A1 (%) Rising phase 0.39 6 0.03 0.13 6 0.01 0.14 6 0.02
Falling phase 0.47 6 0.02 0.41 6 0.02 0.12 6 0.01
t1 (ms) Rising phase 90 6 1 64 6 6 32 6 4
Falling phase 59 6 1 56 6 49  6 1
A2 (%) Rising phase 0.26 6 0.01
t2 (ms) Rising phase 308 6 20
*Fluorescence signals (Fig. 13) were measured from the TMRM-labeled
WT-GAT1 upon voltage jump from 240 to 2140 mV (rising phase) and
back to 240 mV (falling phase), and fit to the equation, F(t) = SAi exp(2t/
ti) 1 C.  Data are presented as mean 6 SEM (n = 4).502 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
Effect of a Transport Inhibitor
The GAT1 inhibitor, NO-711 (Fig. 13 A), was studied for
its effect on the ﬂuorescence and charge movement of
GAT1. NO-711 blocked the charge movements of GAT1
during voltage jumps, as found in earlier studies (Mager
et al., 1993, 1994). Also, in more than 20 cells studied,
NO-711 decreased the ﬂuorescence relaxations (Fig. 13
B). The effect of NO-711 on the ﬂuorescence amplitude
was also studied at various test potentials, and the results
are shown in Fig. 13 C. NO-711 decreased the ﬂuores-
cence by z80% at hyperpolarizing membrane voltages.
The W68L Mutation Shows Fluorescence Relaxations Only at 
High Positive Potentials
We also labeled oocytes expressing the GAT1-W68L
mutation (Kleinberger-Doron and Kanner, 1994; Mager
et al., 1996). The ﬂuorescence labeling intensity from
6 W68L oocytes was 105% that of 10 WT oocytes in the
same batch; this small difference is not signiﬁcant. Yet
in each of two oocyte batches, the ﬂuorescence relax-
ations from GAT1-W68L oocytes were quite small over
most of the voltage range: detectable signals were
noted only at the most positive membrane potentials
and were only z0.2% in amplitude (Fig. 14). The only
relaxations large enough for kinetic analysis were
evoked by the jump from –40 mV to 160 mV; the time
constant was 133 6 14 ms, greater than that either for
the WT or C74A transporter and 2-3 times larger than
the time constant for W68L charge movements under
similar conditions (Mager et al., 1996). We emphasize
that WT-GAT1 yielded normal ﬂuorescence relaxations
signals in oocytes from the same batches.
That W68L-GAT1 produces detectable ﬂuorescence
relaxations under jumps to high positive potentials ﬁts
well with the idea that the ﬂuorescence relaxations mon-
itor transitions of active transporters. In previous studies,
W68L-GAT1 showed GABA transport and transport-asso-
ciated currents ,10% those of WT-GAT1 (Kleinberger-
Doron and Kanner, 1994; Mager et al., 1996). Further-
more, the relation between charge movements and
membrane potential for W68L is shifted toward the right
by z130 mV compared with the WT transporter. Only
small charge movements are observed, and only for
jumps to membrane potentials more positive than 140
mV (Mager et al., 1996). Fig. 14 (top) conﬁrms that slow
capacitive transients, indicative of W68L-GAT1 charge
movements, occur only at the high positive potentials
where the ﬂuorescence relaxations are also observed.
DISCUSSION
These experiments introduce simultaneous measure-
ments on electrophysiology and ﬂuorescence for the
Figure 12. Effect of extracellu-
lar Na1 concentration on the ﬂu-
orescence signal. (A) The ﬂuo-
rescence traces are the averaged
traces from four cells. The curves
show single-exponential ﬁts to
the traces. The membrane po-
tential was held at 240 mV,
stepped to a test potential of
2140 mV for 800 ms, and then
jumped back to the 240-mV
holding potential. The recording
solution was ND96, as described
in the materials and methods,
in which Na1 was substituted
with various concentrations of
NMDG. The residual small ﬂuo-
rescence at 0 [Na1] (z0.05%)
was subtracted from each trace
to show the Na1-dependent ﬂuo-
rescence signal. (B) The ampli-
tude of the ﬂuorescence change,
plotted as a function of the Na1
concentration. The curve repre-
sents the equation DF/F  5  a
[Na1]1.8. (C) The rate constants
of single-exponential ﬁts to the
rising phase of the ﬂuorescence
relaxation are plotted as a func-
tion of Na1 concentration. The linear ﬁt is superimposed on the data, and the slope equals 64 M21 s21. (D) Rate constants from single-
exponential ﬁts to the falling phase of the ﬂuorescence for the jump from 2140 to 240 mV are plotted as function of Na1 concentration.
The lines connect the data points. For all panels, data points are mean 6 SEM (n 5 4 cells). 503 Li et al.
study of a neurotransmitter transporter. The data show
that speciﬁc ﬂuorescence signals are obtained when
the GABA transporter GAT1 is subjected to jumps in
membrane potential. Proof that the signals arise di-
rectly from functional GAT1 comes from several facts.
(a) The signals depend absolutely on GAT1 expression.
(b) The point mutant C74A produces distinct signals.
(c) The poorly functional W68L transporter displays
WT levels of steady state ﬂuorescent labeling, but only
small relaxations and only under the same restricted
conditions that also produce charge movements. The
results for W68L-GAT1 would be signiﬁcant even if
there were no ﬂuorescence signals at all; the argument
does not depend on the small signals for jumps to 140
and 160 mV, but does depend on the normal level of
ﬂuorescence labeling combined with the absence of
most ﬂuorescence relaxations. (d) The GABA uptake
inhibitor NO-711 blocks the ﬂuorescence relaxations.
These observations eliminate a number of admittedly
unlikely artifacts arising from (a) nonspeciﬁc effects of
membrane protein expression or (b) accessory pro-
teins that might be brought to the membrane by GAT1.
The data also show that part of the ﬂuorescence sig-
nal arises at Cys74, a residue thought to lie in the ﬁrst
extracellular loop (Yu et al., 1998). In the C74A mutant
subjected to similar labeling procedures, the trans-
Figure 13. Effect of GAT1 inhibitor, NO-711, on the ﬂuores-
cence relaxations. (A) The structure of the compound. (B) Typical
traces from one cell in the absence (light trace) and presence
(heavy trace) of 3 mM NO-711. The voltage was held at 240 mV
and stepped to a test potential of 2140 mV. The cells were incu-
bated in ND96 containing NO-711 for at least 5 min before record-
ing. (C) Voltage dependence of the amplitude of the ﬂuorescence
relaxation, recorded in the absence (h) and presence (d) of 3
mM NO-711 (B2). Data points are mean 6 SEM (n 5 6 cells).
Figure 14. The W68L-GAT1 mutant shows signals only at high
positive potentials. The membrane potential was held at 240 mV
and jumped to test potentials between 160 and 2140 mV in 20-
mV increments. The traces show the signals for the jumps to 160,
120, 220, 260, 2100, and 2140 mV, as in Fig. 6. Signals for six
oocytes have been averaged. (A) Voltage-clamp currents. The ar-
rows point to the trace for the jump to 160 mV; this is the only
jump that evoked measurable charge movements. (B) Traces for
the jumps from 240 to 2140 mV and from 240 to 160 mV have
been added to isolate the voltage-dependent capacitive currents
for the jumps to and from 160 mV while subtracting the passive
resistive and capacitive currents. (C) The ﬂuorescence signals;
only the jump to 160 mV evoked ﬂuorescence relaxations large
enough (approximately 20.2%) for kinetic analysis. The jumps to
140 mV are not shown, but also gave barely perceptible charge
movements and ﬂuorescence relaxations.504 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
porter functions nearly normally (Fig. 4), yet the steady
state ﬂuorescence is reduced by z40% (Table I) and
the voltage-dependent fractional change in ﬂuores-
cence is reduced by at least twofold at voltages more
negative than 280 mV (Figs. 5 and 6).
There are non-Cys74 signals as well; these appear to de-
pend linearly on membrane potential. However, the fact
that we measure single but different time constants in the
presence and absence of Cys74 suggests that the signals
are not a simple sum of Cys74 and non-Cys74 com-
ponents, vitiating a clear view of possible interactions
among ﬂuorescent labels. Interpretation of the non-
Cys74 signals is also complicated by four additional obser-
vations about effects of sulfhydryl reagents. (a) In the
present experiments, TMRM labeling could occur at
non-Cys74 sites despite previous reaction with MTSET,
but could also be reversed by subsequent exposure to
MTSET (Table II). (b) Reactivity at Cys residues other
than Cys74 may depend on the functional state of the
transporter (Golovanevsky and Kanner, 1999), and there
are complex interactions involving the analogous posi-
tion in SERT, C109 (Stephan et al., 1999). (c) Rather se-
vere exposure to MTSET is required to alkylate Cys74 (Yu
et al., 1998); concentrations of 1.5 mM (vs. 3.75 mM used
in the present experiments) and incubations of 5 min
(vs. 30 min in the present experiments) produced no
blockade (Bennett and Kanner, 1997). (d) Both TMRM
and MTSET may react with other functional groups
(Means and Feeney, 1971; Kluger and Tsui, 1980).
The ﬂuorescence signals are small, limiting our abil-
ity to resolve their detailed amplitude and time course
under varying conditions. The largest change in ﬂuo-
rescence that we observed, corresponding to voltage
jumps between 160 and 2140 mV, amounted to 0.8%.
Our apparatus works well, as judged by the robust sig-
nals (31%) obtained with a similarly labeled K1 chan-
nel (Mannuzzu et al., 1996). Furthermore, these small
signals occur despite an impressive expression level:
the 80 nC of charge movement corresponds to a trans-
porter density of z20,000/mm2 (Mager et al., 1993).
Despite the small signals, we introduce history indepen-
dence as a test for well-behaved conformational transi-
tions, and we show that quantitative comparisons of
voltage dependence can be made between ﬂuores-
cence and charge movements.
In addition to the challenges posed by temporal analy-
sis of the relaxations, other uncertainties are raised in
evaluating the steady state ﬂuorescence intensities. Previ-
ous studies show that changing the concentration of in-
hibitors, of Na1, or of Cl2 at constant voltage produces
charge movements associated with ion binding to GAT1
(Mager et al., 1993, 1996). Changes in the concentra-
tions of these agents also affect our ﬂuorescence relax-
ations and therefore might also change steady state ﬂuo-
rescence under our baseline conditions (usually 240
mV). However, these variations would be expected to lie
within the same amplitude range as the voltage-jump re-
laxations, ,1%. Signals this small, occurring over several
seconds, would not be distinguishable from drifts caused
by bleaching and oocyte motions. Although the ﬁgures
present aligned baselines, it is likely that exposure to
inhibitors or to varying substrate concentrations has
changed the baseline ﬂuorescence. We think it likely
that the W68L transporter is actually ﬁxed at a steady
state ﬂuorescence level similar to that attained by the
WT transporter only at large negative potentials, be-
cause previous studies suggest that the W68L transporter
is blocked at a point in the transport cycle after the bind-
ing of Na1 and before that of GABA (Mager et al.,
1996). Similar comments apply to the ﬂuorescence in
the presence of NO-711 (Mager et al., 1996).
Despite these limitations, the experiments clearly
show that the ﬂuorescence signals differ in important
ways from the previously known signals, primarily elec-
trophysiological, associated with GAT1 function. The
dependence on membrane potential (Figs. 9 and 10),
GABA (Fig. 11), Cl2 concentration (Fig. 11), and Na1
concentration (Fig. 12) all differ markedly from the
characteristics of the transport-associated currents and
transient charge movements described in previous
studies (Mager et al., 1993, 1996; Lu et al., 1996; Hilge-
mann and Lu, 1999; Lu and Hilgemann, 1999b). The
kinetics of the major ﬂuorescence signal (time constant
of 30–150 ms) are in the range of those expected from
a rate-limiting process in the transport cycle, but de-
tailed analysis shows that the kinetics do not match the
well-studied process associated with Na1 binding to the
transporter. These observations differ from the impres-
sive correlations with electrophysiology obtained in
ﬂuorescence studies on voltage-gated channels (Man-
nuzzu et al., 1996; Siegel and Isacoff, 1997) or, more
relevant, on the Na1-glucose transporter SGLT1 la-
beled at position 457 (Loo et al., 1998).
Nature of the Voltage-induced Fluorescence Signal
The effects of jumping the membrane voltage on GAT1
could have one or more of three physical bases. (a)
Membrane potential changes the electrochemical gra-
dient of the charged GAT1 substrates, Na1 and Cl2.
Under most of our conditions, a hyperpolarizing volt-
age jump increases the electrochemical driving force
for Na1, thus possibly changing the balance of trans-
porters among intermediate states in the transport cy-
cle. (b) A jump in the membrane electrical ﬁeld could
change in the energy barrier for some conformational
changes during GAT1 function. These conformational
changes could involve entire domains of the protein, or
individual side chains. (c) In a related mechanism, the
covalently attached ﬂuorophore itself, which has a sub-
stantial dipole moment, could move in the ﬁeld.505 Li et al.
Changes in ﬂuorescence of reporter groups are
thought to arise from changes either in the polarity of
the immediate environment and/or in quenching by
discrete neighboring moieties. Any of the mechanisms
described above could involve such changes. In addi-
tion, one should consider (d) altered quenching by
ions bound nearby. We also cannot rule out changes in
quenching due to interactions between neighboring
ﬂuorophores, although modern studies have shown no
evidence that transporters similar to GAT1 exist as mul-
timers (Eskandari et al., 1998).
The fact that the ﬂuorescence signal from WT-GAT1
is a nonlinear function of voltage argues against hy-
potheses c and d, which would be expected to produce
effects that are linear, at least to ﬁrst order, with the
membrane ﬁeld. A related observation, that W68L-
GAT1 displays ﬂuorescence relaxations only at the high
positive potentials that also permit conformational
changes (Fig. 14) (Mager et al., 1996), supports the hy-
pothesis that the ﬂuorescence changes do not originate
from nonspeciﬁc movement of charged groups within
the electrical ﬁeld in response to voltage jumps. There-
fore, we conclude that the ﬂuorescence relaxation ob-
served in GAT1 corresponds to a conformational
change of GAT1 induced either by increased electro-
chemical driving force of Na1 and/or by a decreased
energy barrier between two conformational states of
GAT1.2 In fact, these two mechanisms may be indistin-
guishable at the level of the ﬁnest details of the trans-
port mechanism (Su et al., 1996; Lester et al., 1996).
Nature of the Fluorescent State
A conformational change produces the ﬂuorescence
signal. Conformational changes form the basis of ki-
netic-state models for GAT1 function studied by Hilge-
mann and Lu (1999). Their favored model is shown in
Fig. 15. Dr. Hilgemann kindly spent some effort at in-
vestigating states in this model that might parallel our
signals, but was unable to correlate the ﬂuorescence sig-
nals shown here with a kinetic state in their model. We
suggest that the ﬂuorescence relaxations observed with
TMRM-labeled GAT1 accompany transitions to and
from a novel intermediate state that was not detectable
in the experiments of Hilgemann and Lu (Fig. 15).
Hilgemann concluded that the transition from E*out to
Eout is voltage dependent, occludes a Na1 onto the
transporter, and constitutes the major rate-limiting step
in the transport cycle (Hilgemann and Lu, 1999). It is
therefore not surprising that an additional detection
technique—ﬂuorescence labeling in this case—has pro-
duced evidence for the existence of an additional step
during this complex E*out to Eout transition. Because the
novel state lies between the two states, E*out and Eout, we
term the new state E*out-ﬂuo. Our measurements do not
accurately reﬂect the steady state ﬂuorescence, but do
track changes from this baseline level; therefore, the
measurements are expected to reﬂect primarily the rel-
ative levels of E*out-ﬂuo and the two adjacent states, E*out
and Eout. Fig. 15 explains how the scheme accounts for
the data in the present study: membrane potential,
Na1, NO-711, and the W68L mutation all affect the ﬂu-
orescence relaxations strongly, while Cl2 and GABA af-
fect the relaxations more weakly, if at all.
We were initially surprised that GABA does not
strongly affect the relaxations. However, we emphasize
that most transporters are thought to reside in the
states that include E*out, E*out-ﬂuo, and Eout, both in the
presence and absence of GABA (Lester et al., 1996;
Hilgemann and Lu, 1999). This point accounts for the
relative lack of GABA effects on the relaxations.
Our study thus supports kinetic models in which mul-
tiple conformational changes occur during neurotrans-
mitter transporter function, and our data suggest that
one such conformational change comprises part of the
transition previously thought to limit the rate of trans-
port (Mager et al., 1993, 1996; Hilgemann and Lu,
1999). Because ion-coupled transport can be simulated
in the absence of conformational changes (Su et al.,
1996), this is a noteworthy observation. The magnitude
of the ﬂuorescence changes that we observe is very
small; therefore, we cannot yet make quantitative state-
ments about the newly identiﬁed intermediate state.
However, much of our data suggests that E*out-ﬂuo is
poorly populated under the conditions of all our ma-
nipulations. The ﬂuorescence relaxations show no sign
of saturation with hyperpolarizing voltage even at the
most negative potentials studied (2140 mV); thus, at
most half the transporter population is in the ﬂuores-
cent state. The signal also shows no sign of saturation
with Na1 concentration even at the highest levels stud-
ied (96 mM); this implies a similar factor of 50%. We
shall assume that these factors are multiplicative, imply-
ing that even our largest signals correspond to an E*out-
ﬂuo occupancy of at most 25%. Perhaps only a few per-
cent of the transporters are in E*out-ﬂuo. This hypothe-
sis also partially explains (a) the small size of the signal
and (b) the fact that E*out-ﬂuo escaped detection in the
experiments of Lu and Hilgemann (1999a,b).
Relationship to Other Work
We believe that we have detected a conformational
change in GAT1 near Cys74. The importance of this re-
2On the other hand, the linear voltage dependence of the fluores-
cence signal from the C74A mutant would be explained by contribu-
tions from any or all of these four mechanisms. However, W68L-
GAT1 both undergoes conformational changes and displays fluores-
cence relaxations, only at positive potentials, suggesting that even the
C74A signals arise from specific conformational changes. We have lit-
tle data to suggest the nature of the conformational changes moni-
tored by the C74A signals and will not consider them further.506 Fluorescence Kinetics of g-Aminobutyric Acid Transporter
gion in GAT1 function was also revealed by other stud-
ies. Amino acid residues near Cys74 are proposed to be
the Na1 or Cl2 binding site: this region is most con-
served in the Na1, Cl2-dependent neurotransmitter
transporter family, and Arg 69 and Trp 68 in this re-
gion, the putative role of which is to interact with ions,
are absolutely required for GAT-1 function (Pantano-
witz et al., 1993; Kleinberger-Doron and Kanner, 1994;
Mager et al., 1996).
That the ﬂuorescence does not directly monitor the
GABA-transporter interaction agrees with previous sug-
gestions that the extracellular loops between TM7 and
TM8 and between TM11 and TM12 are involved in
GABA binding (Tamura et al., 1995). Therefore, it is
very possible that the conformational change we de-
tected near Cys74 between TM1 and TM2 does not in-
volve any structural changes in TM7 to TM12 that are
induced by GABA binding.
Figure 15. The nature of the ﬂuorescent state: a scheme that ﬁts the available data. The scheme is superimposed on the state diagram
accompanying Lu and Hilgemann (1999). The ﬂuorescent state is pictured as a novel state, E*out-ﬂuo between the E*out and Eout states, with
characteristics intermediate to these states. Hilgemann and Lu (1999) concluded that the transition from the E*out to Eout is voltage depen-
dent, occludes a Na1 onto the transporter, and constitutes the major rate-limiting step in the transport cycle. Because the transition is in-
complete in the novel state, with Na1 only partially occluded, the Na1 concentration dependence and voltage dependence for the transi-
tion from E*out to E*out-ﬂuo are less than those for the complete transition to Eout. The dashed oval is drawn to include the novel state and
the immediate adjacent stable states; any agents that act within the oval would perturb the ﬂuorescent state strongly enough to be detected
in our experiments. The W68L mutant is thought to trap transporter in the state now characterized as Eout (Mager et al., 1996), which ex-
plains how this mutation eliminates the ﬂuorescence relaxations at most potentials. NO-711 is thought to stabilize the Eout states as well
(Mager et al., 1996), explaining how it blocks the relaxations. Agents that act outside the oval would perturb the ﬂuorescent state too
weakly to be detected in our experiments. The binding of both GABA and Cl2 occur outside the oval, which explains their small effects on
the ﬂuorescence relaxations. Therefore, GABA binding and Cl2 binding are shown in parentheses.507 Li et al.
The GAT1 Fluorescence Signal Recalls a Phenomenon at 
Serotonin Transporters
The serotonin transporter SERT has z40% sequence
similarity to GAT1, and therefore the two transporters
presumably share overall structural details. We feel jus-
tiﬁed in comparing some functional phenomena as
well between SERT and GAT1. At SERT, jumps to hy-
perpolarizing voltages induce the transient activation
of a channel-like conducting pathway (Mager et
al., 1994). Thus, SERT displays a hyperpolarization-
induced conformational change. Several characteristics
of this state at SERT resemble those of the state we
term E*out-ﬂuo at GAT1. (a) Voltage dependence: both
increase with hyperpolarizing voltages with no sign of
saturation at membrane voltage of 2140 mV. (b) Na1
dependence: both increase with increasing Na1 con-
centration with a Hill coefﬁcient of 1.7–1.8. (c) Cl2 de-
pendence: both are affected by Cl2 to a lesser degree
than by Na1. (d) Substrate dependence: both occur
in the absence of the respective neurotransmitter. (e)
Time course: both the GAT1 ﬂuorescence signal and
the inactivation of the SERT conductance occur on
time scale of z100 ms.
If a state like E*out-ﬂuo does produce the transient re-
sistive current in SERT, then E*out-ﬂuo contains a chan-
nel-like pathway in SERT but not in GAT1. Perhaps this
partially occluded state, which we have already drawn
as extending nearly through the molecule (Fig. 15), is
actually open to both sides in SERT. Indeed, several
studies suggest that a channel-like pathway also exists in
GAT1 (Cammack et al., 1994; Cammack and Schwartz,
1996; Risso et al., 1996). Because channel-like behav-
iors of neurotransmitter transporters are being investi-
gated intensively (Mager et al., 1994; Cammack and
Schwartz, 1996; Sonders et al., 1997; Petersen and De-
Felice, 1999; Galli et al., 1998), ﬂuorescence experi-
ments may become a useful tool.
Outlook
Over the past decade, electrophysiological experiments
have revealed the existence of several previously unsus-
pected states at neurotransmitter transporters. We have
shown how to conduct ﬂuorescence measurements on
a neurotransmitter transporter. We conclude that our
measurements monitor a novel conformational state of
GAT1, but this state has properties intermediate be-
tween those of two known states, and it may resemble a
previously described state of SERT. We expect that it
will be possible to measure ﬂuorescent signals associ-
ated with labeling of other GAT1 residues. We hope
that some of these future signals will be larger and
therefore more amenable to quantitation.
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